Tongyang Life Insurance (082640) 🔎 In-depth
KOSPI · Price as of 2026-08-06 · Updated 2026-08-09
Tongyang Life Insurance is a life insurer selling individual protection and savings and annuity policies, with earnings coming from two streams: insurance-operating profit (managed through CSM) and investment income from putting premiums to work. In 2025 consolidated revenue was about ₩2.3108 trillion and net profit attributable to controlling interests was ₩124.4 billion; then, by a board resolution in April 2026, the company decided on a 'comprehensive share swap' that will fold it into Woori Financial Group as a 100% wholly owned subsidiary and take it through delisting (swap price ₩8,720 per share, share-swap date August 11). What stands out lately is that the fixed swap price of ₩8,720 and the appraisal-and-purchase price of ₩8,505 are both above the current price (₩7,450), so a gap exists if the process proceeds as scheduled, whereas the swap consideration is new Woori Financial shares - so the final value is tied to Woori Financial's stock price - and procedural risks such as passing the shareholder meeting remain.
This page organises public market and filing data for information purposes. It is not a recommendation to buy or sell, nor investment advice. Metrics labelled “forward” are our own unverified estimates. Please verify with the original DART filings and decide at your own responsibility.
30-second brief
Pulled directly from the computed values below — not a separately written opinion.
What do the SourceComputedEstimateReading tags mean?
Source filings and exchange data · Computed calculated from public data · Estimate our own unverified projection · Reading drafted automatically, then rule-checked. See AI & Automation.
Core valuation metric
This stock's effective sub-sector is “Insurance” (Financials), a type typically read first through P/B.
For insurers, the base of the business is the pool of assets and reserves they hold, while accounting profit can swing sharply year to year with investment results and reserve changes. That makes price-to-book (P/B) — the price against net asset value — a steadier gauge than earnings multiples.
Price against assets alone says little about where the cycle stands. Reading it together with price against this year's expected earnings shows how far profits have recovered.
This note explains how each sector is typically valued and is educational context only, not investment advice.
At-a-glance assessment financial health · growth · profitability · valuation
- For financial companies, debt and interest costs are large by the nature of the business, so the debt ratio and interest coverage cannot be read on the same yardstick as an ordinary company.
- Revenue rose 2.0% year over year, and the pace is slowing (3-year trend: rising).
- Most recent quarter (Q1 2026) revenue was 45.7% higher than a year earlier.
- ROE is 5.6% (total-net basis). It is above the sector average.
- Operating margin is 6.7%.
- A sector-metric and in-depth research verdict — see “Valuation vs peers” below for the basis.
Ownership & governance As of 2025-12-31
Largest shareholder Woori Financial Group 75.34% (corporate)
Controlling bloc incl. related parties 75.46%
With the controlling bloc holding 75%, control is very secure but the free float is thin.
🔎 In-depth analysis Reading
Tongyang Life Insurance is a life insurer selling individual protection policies (whole-life, term, health) and savings and annuity policies. An insurer's profit comes from two streams. One is insurance-operating profit (the margin left after taking in premiums and reserving for future claims; under the new accounting standard it is managed as CSM - the contractual service margin, which builds a contract's future profit in advance). The other is investment income (profit from putting premiums received from customers to work in bonds, equities, and the like). In 2025 consolidated revenue (insurance-operating revenue and so on) was about ₩2.3108 trillion, and net profit attributable to controlling interests was ₩124.4 billion. That total assets of about ₩35 trillion exceed shareholders' equity (₩1.5489 trillion) by more than 22 times is characteristic of insurers, because policy reserves (liabilities) owed back to customers make up most of the assets. A general manufacturer's debt-ratio yardstick therefore should not be applied directly.
The latest close is ₩8,250 and the market capitalization is ₩1.3 trillion. The price sits above its 20-day moving average (₩7,893) and above its 60-day moving average (₩7,681). It holds above both its short- and medium-term moving averages, so the trend looks healthy. The RSI (a supplementary indicator that gauges the strength of gains versus losses over the past 14 days on a 0-100 scale) is 60.9, a neutral level. The one-month change is +5.8%, the three-month change is +2.2%, and the position relative to the 52-week high is -9.3%. Relative strength versus the KOSPI is 46 (on a 1-99 scale, converted from returns against the index over the past year with more weight on recent performance; higher means stronger than the market). It is stronger than roughly 46% of all stocks. Over the past three months it outpaced the index by 20.9%. Chart interpretation is best done alongside trading volume and the dates on which disclosures occur.
On the current price, valuation is a P/E ratio (how many times one year's net profit the price represents) of 10.34x and a P/B (how many times net asset value per share the price represents) of 0.70x, trading below book value. Profitability, with an ROE (how much is earned in a year on equity) of 8.0%, is on the good side for the life-insurance sector. That said, 2025 net profit (₩124.4 billion) embeds a sharp year-on-year drop, so an undervaluation cannot be called on the P/E based on last year's confirmed figure alone. First-quarter 2026 net profit was ₩25.0 billion, down 46% year on year; insurance-operating profit itself improved, and the main cause was a plunge in investment income. In other words, it was a quarter in which the investment side, rather than the core insurance business, shook the results.
Over a three-year trend, revenue rose gently (from ₩2.1194 trillion in 2023 to ₩2.3108 trillion in 2025, a +4.4% average annual gain). By contrast, operating profit and net profit, after peaking in 2024, fell 46% and 60% respectively in 2025. This reflects not a slowdown in growth but the nature of insurer earnings, where investment income swings with the interest-rate and asset-price environment. In the first quarter of 2026, insurance-operating profit improved but investment income plunged, leaving net profit at ₩25.0 billion. That said, this company's value this year hinges less on such earnings swings than on the share-swap and delisting process scheduled for August and the swap price (₩8,720).
The most important disclosure is the 'comprehensive share swap' resolved at the board on April 24, 2026 and contracted on April 29. Under it, Tongyang Life will be folded into Woori Financial Group as a 100% wholly owned subsidiary and go through delisting. The swap ratio is 0.2521056 Tongyang Life shares per Woori Financial Group share, and the Tongyang Life swap price is ₩8,720 per share (dissenting-shareholder appraisal-and-purchase price ₩8,505). The schedule sets the extraordinary shareholder meeting for July 24, 2026, the dissenting-shareholder appraisal-and-purchase exercise period from July 24 to August 3, a trading halt from August 7 to August 28, and the share-swap date on August 11. In May there was some procedural fine-tuning, including an amendment to the material-fact report following a correction order from the financial authorities, and April brought a results disclosure (preliminary first quarter), an IR announcement, and a treasury-share cancellation decision.
This stock is more accurately read as an M&A special situation than through the usual 'cheap/expensive' valuation. The strong conditions are clear. The fixed swap price of ₩8,720 and the dissenting-shareholder appraisal-and-purchase price of ₩8,505 are 17% and 14% above the current price (₩7,450) respectively, so a gap exists between the current price and the swap value if the process proceeds as scheduled. The cautions are just as clear. First, the swap consideration is not cash but new Woori Financial Group shares, so the final value moves with Woori Financial's stock price. Second, minority shareholders are pushing back on the swap ratio, so procedural risks remain around passing the shareholder meeting and the scale of dissenting-shareholder appraisal-and-purchase claims. Third, after delisting in late August the only choices left are to hold Woori Financial shares or to cash out via an appraisal-and-purchase claim. Core-business results (earnings swings from investment-income volatility) are a secondary variable in this phase.
🔎 Valuation vs peers Inconclusive
Compared against domestic listed life and non-life insurers; however, since Tongyang Life is a special situation slated for delisting, its position relative to the swap price matters more than a pure valuation comparison.
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Samsung Life Insurance | 24.97x | 0.71x | 3.53% |
| Hanwha Life Insurance | 6.20x | 0.26x | 4.84% |
| Samsung Fire & Marine Insurance | 14.33x | 1.20x | 8.47% |
| DB Insurance | 5.85x | 0.90x | 13.79% |
Within the life-insurance sector, Tongyang Life's P/B of 0.75x and ROE of 8.0% are lower than Samsung Life (P/B 1.18) and Samsung Fire & Marine (1.29) and higher than Hanwha Life (0.28), so it does carry an undervalued character relative to net assets and profitability. That said, last year's net profit was an inflection point that dropped sharply on investment-income swings, so an undervaluation cannot be called on last year's confirmed P/E alone. Above all, this stock has a confirmed folding into Woori Financial Group as a wholly owned subsidiary and delisting, so the yardstick of value is not an earnings multiple but the swap price (₩8,720 per share) and Woori Financial's stock price, the swap consideration. The current price is about 17% below the swap price, but because the consideration is new Woori Financial shares rather than cash there is exposure to Woori Financial's price movement, and procedural risks such as minority-shareholder pushback on the swap ratio remain, so we leave it inconclusive rather than concluding a simple undervaluation.
Price history Close · MA20 · MA60
The latest close is ₩8,250 and the market capitalization is ₩1.3 trillion. The price sits above its 20-day moving average (₩7,893) and above its 60-day moving average (₩7,681). It holds above both its short- and medium-term moving averages, so the trend looks healthy. The RSI (a supplementary indicator that gauges the strength of gains versus losses over the past 14 days on a 0-100 scale) is 60.9, a neutral level. The one-month change is +5.8%, the three-month change is +2.2%, and the position relative to the 52-week high is -9.3%. Relative strength versus the KOSPI is 46 (on a 1-99 scale, converted from returns against the index over the past year with more weight on recent performance; higher means stronger than the market). It is stronger than roughly 46% of all stocks. Over the past three months it outpaced the index by 20.9%. Chart interpretation is best done alongside trading volume and the dates on which disclosures occur.
Relative performance stock vs index · start = 100
Excess return vs index · 3M +20.86% / 6M -6.01% / 12M -49.30%
Key metrics Computed vs whole-market median
Valuation
The P/E of 10.34x is below the whole-market median (12.97x). The P/B of 0.70x is below the whole-market median (0.84x). Both metrics are low versus peers, so the price is not expensive relative to earnings and assets.
Profitability & financials
Return on equity (ROE) is 5.6%, above the whole-market average (3.0%). The operating margin is 6.7%. The debt ratio is 1770.4%, but for financial firms deposits and insurance liabilities count as debt, so it cannot be read on the same yardstick as an ordinary company.
Growth FY2025 · annual report (consolidated)
| Item | 2023 | 2024 | 2025 | YoY |
|---|---|---|---|---|
| Revenue | $1.5B | $1.6B | $1.6B | +1.98% ↓ slower |
| Operating profit | $206.7M | $258.6M | $139.7M | -45.98% ↓ slower |
| Net profit | $168.5M | $220.8M | $87.5M | -60.39% ↓ slower |
| 5-year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | $1.5B | $1.6B | $1.6B |
| Operating profit | — | — | $206.7M | $258.6M | $139.7M |
| Net profit | — | — | $168.5M | $220.8M | $87.5M |
| Revenue CAGR | 2-yr avg 4.42% | ||||
Revenue rose 2.0% year over year (2023 ₩2.1 trillion → 2024 ₩2.3 trillion → 2025 ₩2.3 trillion), and the three-year trend is 'rising'. That said, the pace of growth slowed from the prior year. Operating profit fell 46.0% year over year. The decline widened. Over the 3 years on record, revenue compound annual growth (CAGR) is 4.4%. The two-year revenue CAGR is 4.4%. In the most recent quarter (Q1 2026), revenue was 45.7% higher than the same period a year earlier.
Latest quarterly results Source Q1 2026 · vs year-ago
Technical indicators Computed
What stands out
- P/E and P/B are both low versus peers, so the price looks inexpensive relative to earnings and assets.
Points to watch
- Revenue rose 2.0% year over year, and the pace is slowing (3-year trend: rising).
Recent news & events searched · sourced
- 2026-04-24FilingBoard resolution on a comprehensive share swap into Woori Financial Group. Tongyang Life will be folded in as a wholly owned subsidiary and delisted. Swap ratio 1 Woori Financial : 0.2521056 Tongyang Life, with a Tongyang Life swap price of ₩8,720 per share.The largest event, changing the company's ownership structure and listing status themselves. Shifts the stock into a special situation tied to the swap price and Woori Financial's stock price. Source
- 2026-04-24EarningsDisclosure of preliminary first-quarter 2026 consolidated results. Net profit of ₩25.0 billion, down about 46% year on year; insurance-operating profit improved but investment income plunged.The core insurance business improved, but net profit fell on investment-side swings. In the delisting phase, however, results have limited influence on the stock price. Source
- 2026-04-24FilingDecision on treasury-share cancellation and resolution to convene an extraordinary shareholder meeting (scheduled July 24). The procedure for handling the share-swap agenda begins.Advances the process toward share-swap approval. The treasury-share cancellation is a measure related to shares outstanding and shareholder value. Source
- 2026-05-26UpdateFollowing a correction order from the financial authorities, the material-fact report (share-swap and transfer decision) filed on May 14 became subject to amendment.Procedural coordination and supplementation are needed for the share swap. Not a change that overturns the schedule itself, but it confirms the presence of procedural risk. Source
- 2026-04-29IRDisclosure announcing an IR event. Explains the first-quarter results and the company's stance on the share swap.A channel for communication with shareholders and the market. An official channel for the company's explanation of the swap ratio and future plans. Source
Figure cross-check computed ↔ external
Recent filings Source
- 2026-05-29PeriodicQuarterly report (amended)
- 2026-05-26Material-fact report (amended)
- 2026-05-15PeriodicQuarterly report
- 2026-05-14Material-fact report (amended)
- 2026-05-13OwnershipLargest-shareholder ownership change report
- 2026-04-29Material-fact report (amended)
- 2026-04-29Disclosure
- 2026-04-24EarningsFair-disclosure notice
- 2026-04-24Disclosure
- 2026-04-24Shareholders' meeting notice
- 2026-04-24Disclosure
- 2026-04-24Material-fact report
📖 Plain-language glossary — expand if you are new to this
- P/E
- How many times a year's net profit the price is worth (lower is cheaper relative to earnings). The P/E here is on trailing (last full-year) results; for companies whose earnings swing fast (memory chips and other cyclicals/high-growth), a forward P/E on this year's expected earnings is more accurate.
- P/B
- Price relative to net assets (equity). Around 1x means it trades near book value; below 1x means below book.
- P/S
- Price relative to a year's revenue — useful for growth companies with thin earnings.
- Net debt / EV
- Net debt = interest-bearing debt − cash. Negative means more cash than debt (net cash). EV (enterprise value) = market cap + net debt, closer to what it would cost to buy the whole business.
- EV/EBIT · EV/EBITDA · EV/Sales
- Enterprise value against operating profit (EBIT), EBITDA, or revenue. Unlike P/E these reflect debt and cash; lower is cheaper relative to earnings power or sales.
- FCF / FCF yield
- Free cash flow = operating cash − capex, the cash actually left over. FCF yield = FCF ÷ market cap; higher means more cash generated per unit of market value.
- Intrinsic value (DCF)
- Future free cash flow (or, for some capex-heavy but profitable names, forecast earnings) discounted to today to estimate per-share value. Because it shifts a lot with the discount-rate and growth assumptions, it is shown as a bear/base/bull range, and the basis and assumptions are disclosed in one line beneath it.
- ROE
- How much profit the company earns in a year on its equity (%). Higher means better returns on capital.
- EPS / BPS
- Earnings per share / net assets (book value) per share.
- Operating / net margin
- Profit left from the core business / final profit after tax and interest, per unit of revenue.
- Debt ratio
- Debt relative to equity (%). Higher means more reliance on borrowing (norms vary by sector).
- Current ratio
- Assets convertible to cash within a year against debt due within a year. Above 100% leaves some short-term headroom.
- Interest coverage
- How many times operating profit covers the interest owed. Below 1x means operating profit alone struggles to cover interest.
- Dividend yield / payout ratio
- The year's dividend as a % of today's price / the share of earnings paid out as dividends.
- Revenue CAGR
- Multi-year growth expressed as a single yearly average (compound annual growth rate).
- RSI (short-term signal)
- Whether recent price action is overheated or beaten down. Above 70 is overbought, below 30 oversold.
- MA20 / MA60 (moving averages)
- The 20- and 60-day average price. Price above them signals a firmer short-term trend.
- vs 52-week high
- How far below the past year's peak the price sits now (%).
All figures are for reference only; how they read varies by sector and over time.
Sources: Korea FSC market-price API (data.go.kr), OpenDART, KRX/KIND — public data only.
Bong Stocks presents public-data-based information for reference only. It is not investment advice and contains no target prices, ratings, or buy/sell recommendations. Verify independently before making any decision.